News

The A0081186 trial is a 12-month randomized double-blind study that enrolled more than 700 patients, who received either a placebo, Lyrica at 300 mg/day, pramipexole at 0.25 mg/day

The move was made following the termination of collaboration between both the companies. AbGn-168H, a humanized monoclonal antibody against CD-162 preferentially induces apoptosis of late-stage activated T-cells and

The platform enhancement also offers the ability of reporting additional ancillary services in the future. The Healthesystems State Reporting Tool has been developed to accommodate the many nuances

Omega-sterol was clinically proven to be effective for blood lipid control and for supporting healthy levels of both blood triglycerides and LDL-cholesterol (bad cholesterol) in humans, the company

The company says the financing proceeds will be used to complete a randomized Phase 2 trial of CRLX101 in non-small cell lung cancer, and to support other investigator-sponsored

The company entered a field-exclusive option agreement with Harvard University to negotiate a license under patent rights that cover prophylactic uses of a modified anthrax toxin protein. The

According to the company, the new protein products offer good taste besides being beneficial for health. The company says that currently there is a need for protein and

According to the company, Truvada once approved would be the first agent indicated for uninfected individuals to reduce the risk of acquiring HIV through sex, a prevention approach

The facility in Nansha operates two small scale trains supplying clinical material, three large scale API trains for metric tons, and cGMP laboratories to meet gram-scale demands. The